Combination therapy with savolitinib and osimertinib shows promising results in treating advanced NSCLC with EGFR mutations ...

Combination therapy of osimertinib and datopotamab deruxtecan shows promising efficacy in advanced NSCLC, warranting further ...

Back in May 2025, dapiglutide failed to impress in a phase 2 trial, mustering up to an average 4.3% reduction in weight loss when given at the 6-mg dose. The 54-person study involved administering ...

PureBulk, a provider of high-purity, clean supplements, today announced the launch of its new product, Tasty Clear Electrolytes. This high-potency electrolyte mix is formulated to meet the needs of ...

An FIR was registered under sections 125 (act endangering life or personal safety of others), 125(a) (causing hurt by act ...

Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised staging system for NKTCL.

Find out what's new in natural innovations including grocery products, ingredients, dietary supplements, branded ingredients and more!